News

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine ...
AI is reshaping labs and Clever Culture’s tech is gaining Big Pharma attention as diagnostics and cleanrooms go digital.
AstraZeneca has been successful at rolling ... meningococcal vaccination status or prophylactic administration of antibiotics prior to treatment with Ultomiris. Data have suggested that ...
While India grapples with rising Covid cases and prepares for potential biological threats, the government's neglect of its ...
The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...
Across the world, there are reports of shortages of common antibiotics. Ben Hargreaves examines why these shortages are happening and what is being done in the background to return supply to normal.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Despite the crucial need for new antibiotics, there has been little innovation in the past 20 years. According to a report from the Biotechnology Innovation Organization, “more than 82% of all ...